pentobarbital will lower the extent or effect of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Solid CYP3A4 inducers may possibly minimize partiaprevir and ritonavir stages, and thus diminished efficacy of Viekira P